NASDAQ, PPDI - Pharmaceutical Product Development
We are a leading global contract research organization providing drug discovery
and development services, post-approval expertise and compound partnering
programs. Our clients and partners include pharmaceutical, biotechnology,
medical device, academic and government organizations. Our corporate mission is
to help clients and partners maximize returns on their research and development
investments and accelerate the delivery of safe and effective therapeutics to
patients.
We have been in the drug development business for more than 22 years. Our
development services include preclinical programs and Phase I to Phase IV
clinical development services as well as bioanalytical product testing and
clinical laboratory services. We have extensive clinical trial experience,
including regional, national and global studies across a multitude of
therapeutic areas and in various parts of the world. ...
Read SEC Filing on NASDAQ.com »